News Detail
Chandigarh, 5 March 2025: Following information received by the Drugs Control Wing under the Food and Drugs Administration (FDA) in Punjab about misuse of seven H and H1 drug formulations for intoxication, the drug control wing has wanted all the regulatory officers to track the ......
View Details
Source : Pharmabiz
Drugs Control Wing
FDA in Punjab
misuse
H1 drug
intoxication
C&FAs
wholesalers
retailers
pregabalin
gabapentin
dicyclomine
tapentadol
zopiclone
flupentixol
carisoprodol
Related News
- Bombay HC says drug addiction a 'quasi pandemic', calls for model FIR in NDPS cases (06-03-2025)
- Telangana DCA introduces 'Third Party Verification (TPV)' system to verify genuineness of license holders (06-03-2025)
- ICMR Publishes 'Ethical Requirements for Research in Integrative Medicine' (06-03-2025)
- Wipro GE Healthcare launches ‘AI Enabled’ ultrasound system (06-03-2025)
- Gujarat FDCA to equip drug inspectors with high-tech spectrophotometers for onsite testing (06-03-2025)
- CDSCO launches online registration process for CROs (05-03-2025)
- FDA warns Granules India over cleanliness and poor record keeping (05-03-2025)
- Fitness Gym Raid: Man held over sale of fake medicines, steroids in Gurugram (05-03-2025)
- 17 states and 3 UTs did not submit NSQ data to Centre in January (05-03-2025)
- UP Court restrains Jamp Pharma from using Jubilant Generics’ confidential data; Grants injunction (05-03-2025)